Trial · NCT06147518
Registered outcomes20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 20
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of patients with glycemic control at 24 weeks (HBA1c <7.0 %) | 24 weeks | |
| Secondary | Percentage of patients with glycemic control at 8 and 16 weeks (HBA1c <7.0 %) | 8 and 16 weeks | |
| Secondary | Ideal body weight loss of ≥3% relative to baseline at 24 week | 24 weeks | |
| Secondary | Incidence and frequency of hypoglycemia (BS <54 mg/dl) episodes | 8 weeks | |
| Secondary | Incidence and frequency of hypoglycemia (BS <54 mg/dl) episodes | 16 weeks | |
| Secondary | Incidence and frequency of hypoglycemia (BS <54 mg/dl) episodes | 24 weeks | |
| Secondary | Changes in HbA1c at 24 week relative to baseline | 24 weeks | |
| Secondary | Changes in BMI at 24 week relative to baseline | 24 weeks | |
| Secondary | changes in Blood insulin at 24 week | 24 weeks | |
| Secondary | changes in lipid profile at 24 week | 24 weeks | |
| Secondary | Change in ALT at 8, 16 and 24 week | 8, 16 and 24 week | |
| Secondary | Change in HVPG at 24 week compared to baseline | 24 weeks | |
| Secondary | Change in LSM at 24 week compared to baseline | 24 weeks | |
| Secondary | Change in SSM at 24 week compared to baseline | 24 weeks | |
| Secondary | Incidence of urinary protein excretion at 8, 16 and 24 weeks | 8, 16 and 24 weeks | |
| Secondary | Incidence of serum creatinine at 8, 16 and 24 weeks | 8, 16 and 24 weeks | |
| Secondary | Number of patients with Complications of cirrhosis (ascites, HE, Bleed, AKI, Infection) at 24 week | 24 weeks | |
| Secondary | Medicine adherence rate in both groups | 24 weeks | |
| Secondary | Adverse effects to study drugs in both groups | 24 weeks | |
| Secondary | Number of patients with Mortality/ Liver transplantation in both groups | 24 weeks |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06147518/registered